BI 836826 is a chimeric mouse–human anti-CD37 monoclonal antibody engineered to enhance binding and effector function that mediates direct antibody-dependent cell-mediated cytotoxicity (ADCC) against CLL cells [11]. This evidence concerns the gene CD37 and B-cell chronic lymphocytic leukemia.